Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul Ahn
Daniel Ahn

Showing results (551-560 of 593) with videos related to

Pageof 60
Sort By:
The Journal of Allergy and Clinical Immunology|October 6, 2012
Distinct TLR-mediated pathways regulate house dust mite-induced allergic disease in the upper and lower airwaysJi-Hwan Ryu, Jung-Yeon Yoo, Min-Ji Kim, et al.
Environmental Monitoring and Assessment|April 19, 2014
Blood levels of cadmium and lead in residents near abandoned metal mine areas in KoreaDong-Uk Park, Dae-Seon Kim, Seung-Do Yu, et al.
Esophagus : Official Journal of the Japan Esophageal Society|December 25, 2025
Preoperative chemoradiotherapy plus pembrolizumab for esophageal squamous cell carcinoma (ACTS-29)Min Hee Hong, Sung Kwan Shin, Su-Jin Choi, et al.
The Oncologist|March 19, 2017
Academic Cancer Center Phase I Program DevelopmentArthur E Frankel, Keith T Flaherty, George J Weiner, et al.
International Journal of Radiation Oncology, Biology, Physics|November 14, 2021
SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation TrialRaquibul Hannan, Samer Salamekh, Neil B Desai, et al.
Hepatology (Baltimore, Md.)|September 24, 2022
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 studyMitesh J Borad, Li-Yuan Bai, Donald Richards, et al.
Nature Medicine|July 2, 2026
Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trialAmbarish Pandey, Neil Keshvani, Syed K Rizvi, et al.
The Oncologist|February 25, 2021
Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal CancerIbrahim Halil Sahin, Subir Goyal, Yoanna Pumpalova, et al.
Pancreas|June 4, 2026
Germline Cancer Testing in Unselected Patients With Neuroendocrine Neoplasms: A Multi-center Prospective StudyOluseyi Abidoye, Michael Golafshar, Katie Kunz, et al.
European Heart Journal|October 12, 2017
Clinical implications of three-vessel fractional flow reserve measurement in patients with coronary artery diseaseJoo Myung Lee, Bon-Kwon Koo, Eun-Seok Shin, et al.
Pageof 60

Showing results (551-560 of 593) with videos related to

Sort By:
Pageof 60
The Journal of Allergy and Clinical Immunology|October 6, 2012
Distinct TLR-mediated pathways regulate house dust mite-induced allergic disease in the upper and lower airwaysJi-Hwan Ryu, Jung-Yeon Yoo, Min-Ji Kim, et al.
Environmental Monitoring and Assessment|April 19, 2014
Blood levels of cadmium and lead in residents near abandoned metal mine areas in KoreaDong-Uk Park, Dae-Seon Kim, Seung-Do Yu, et al.
Esophagus : Official Journal of the Japan Esophageal Society|December 25, 2025
Preoperative chemoradiotherapy plus pembrolizumab for esophageal squamous cell carcinoma (ACTS-29)Min Hee Hong, Sung Kwan Shin, Su-Jin Choi, et al.
The Oncologist|March 19, 2017
Academic Cancer Center Phase I Program DevelopmentArthur E Frankel, Keith T Flaherty, George J Weiner, et al.
International Journal of Radiation Oncology, Biology, Physics|November 14, 2021
SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation TrialRaquibul Hannan, Samer Salamekh, Neil B Desai, et al.
Hepatology (Baltimore, Md.)|September 24, 2022
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 studyMitesh J Borad, Li-Yuan Bai, Donald Richards, et al.
Nature Medicine|July 2, 2026
Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trialAmbarish Pandey, Neil Keshvani, Syed K Rizvi, et al.
The Oncologist|February 25, 2021
Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal CancerIbrahim Halil Sahin, Subir Goyal, Yoanna Pumpalova, et al.
Pancreas|June 4, 2026
Germline Cancer Testing in Unselected Patients With Neuroendocrine Neoplasms: A Multi-center Prospective StudyOluseyi Abidoye, Michael Golafshar, Katie Kunz, et al.
European Heart Journal|October 12, 2017
Clinical implications of three-vessel fractional flow reserve measurement in patients with coronary artery diseaseJoo Myung Lee, Bon-Kwon Koo, Eun-Seok Shin, et al.
Pageof 60